October 3, 2009, 5:25 pmSAN FRANCISCO (AP) -- The former chief executive of the biotechnology company InterMune Inc. has been convicted of wire fraud in marketing of the drug Actimmune.
A federal jury in San Francisco convicted Dr. W. Scott Harkonen after a seven-week trial. He was acquitted of a separate charge of misbranding the drug, the U.S. Department of Justice said Friday.
Harkonen's indictment last year charged that he made false and misleading statements about the drug's effectiveness in fighting the fatal lung disease idiopathic pulmonary fibrosis, known as IPF
.../...
"Mr. Harkonen lied to the public about the results of a clinical trial and offered false hope to people stricken with a deadly disease," FBI Special Agent in Charge Stephanie Douglas said in a statement.
Wire fraud carries a maximum penalty of 20 years in prison and $250,000 fine.
Harkonen was InterMune's chief executive from 1998 until 2003. The Brisbane-based company agreed in October 2006 to a nearly $37 million settlement with the government.
Con razón Bill y Melinda, que no son tontos, sacaron de allá "todos los reales..."
(En PHARMACOSERÍAS lo habíamos dicho)
Entradas
No hay comentarios:
Publicar un comentario